Table 1.
Demographic variables for VA patients compared with patients with other insurance nationally
| Variable | Overall, n=302,457 | VA, n=3663 | Private, n=141,523 | Medicare, n=132,026 | Medicaid, n=25,245 | P Value |
|---|---|---|---|---|---|---|
| Age | 52.4±12.9 | 57.5±9.8 | 51.1±11.9 | 54.9±13.3 | 45.9±13.7 | <0.001a |
| Men | 61.3% | 92.2% | 61.6% | 61.2% | 55.2% | <0.001b |
| Race/ethnicity | <0.001b | |||||
| White | 45.0% | 51.7% | 53.0% | 40.1% | 24.9% | |
| Black | 29.0% | 36.9% | 24.4% | 33.2% | 31.8% | |
| Hispanic | 17.4% | 7.3% | 13.4% | 19.5% | 30.7% | |
| Other | 8.5% | 4.1% | 9.2% | 7.1% | 12.6% | |
| Diagnosis of ESRD | <0.001b | |||||
| Diabetes | 35.5% | 41.8% | 31.4% | 40.1% | 33.3% | |
| Hypertension | 21.7% | 16.7% | 18.2% | 25.2% | 23.5% | |
| GN | 16.9% | 16.5% | 20.8% | 12.8% | 16.9% | |
| Polycystic | 7.4% | 8.3% | 10.8% | 4.4% | 4.4% | |
| Other | 18.5% | 16.6% | 18.9% | 17.4% | 22.0% | |
| Peripheral vascular disease | 5.9% | 5.4% | 4.5% | 7.6% | 5.1% | <0.001b |
| Malignancy | 6.1% | 9.9% | 5.6% | 7.1% | 2.7% | <0.001b |
| Serum albumin | 3.9±0.6 | 3.8±0.5 | 3.9±0.6 | 3.9±0.6 | 3.8±0.7 | <0.001a |
| Education | <0.001b | |||||
| Unknown | 7.6% | 32.1% | 7.4% | 7.1% | 8.5% | |
| High school or less | 47.4% | 24.3% | 37.9% | 54.8% | 65.9% | |
| Some college or more | 44.9% | 43.6% | 54.8% | 38.1% | 25.6% | |
| Dialysis vintage, mo | <0.001b | |||||
| 0 | 30.9% | 31.0% | 44.9% | 16.9% | 25.7% | |
| 1–12 | 32.4% | 23.9% | 33.9% | 29.9% | 37.7% | |
| 13–24 | 18% | 21.5% | 13.5% | 23.0% | 16.5% | |
| 25–36 | 7.7% | 11.2% | 4.6% | 11.1% | 7.3% | |
| >36 | 11.0% | 12.3% | 3.1% | 19.1% | 12.8% | |
| BMI, kg/m2 | <0.001b | |||||
| ≤25 | 27.1% | 19.8% | 26.2% | 26.8% | 34.6% | |
| 26–30 | 33.0% | 36.5% | 32.6% | 33.6% | 31.0% | |
| 31–35 | 24.4% | 32.2% | 25.0% | 24.4% | 20.2% | |
| >35 | 14.3% | 11.2% | 14.9% | 14.1% | 12.9% | |
| Listed inactive | 26.8% | 13.0% | 26.9% | 26.5% | 30.1% | <0.001b |
| Any inactive status | 59.6% | 52.2% | 54.6% | 59.1% | 59.1% | <0.001 |
| Listing era | <0.001b | |||||
| 2004–2007 | 28.2% | 20.1% | 29.0% | 27.6% | 28.6% | |
| 2008–2011 | 32.2% | 31.8% | 32.2% | 32.9% | 29.6% | |
| 2012–2016 | 39.5% | 48.2% | 38.9% | 39.5% | 41.7% | |
| Panel reactive antibody >0% | 16.0% | 8.4% | 15.6% | 16.6% | 16.3% | <0.001b |
| Median distance to transplant center, miles (25%, 75%) | 22.4 (8.9, 65.8) | 281.9 (122.8, 596.9) | 22.7 (9.9, 60.7) | 23.0 (8.4, 69.8) | 13.8 (5.5, 48.6) | <0.001c |
| Transplanted in a center different from primary listing (for those transplanted) | 11.8% | 13.3% | 12.9% | 10.5% | 10.5% | <0.001b |
| Multilisting before removal from list for transplant, death, or other | 5.4% | 6.5% | 6.5% | 4.6% | 3.0% | <0.001b |
| Accept a hepatitis C-positive donor? | 3.1% | 4.4% | 2.9% | 3.2% | 3.5% | <0.001b |
| Community risk score | 19.9±10.2 | 21.4±9.9 | 18.8±10.2 | 21.1±10.0 | 19.5±10.4 | <0.001a |
| Community risk score quintiles | <0.001b | |||||
| 1 | 20.3% | 15.4% | 23.9% | 15.9% | 22.9% | |
| 2 | 19.6% | 17.2% | 20.5% | 18.7% | 19.9% | |
| 3 | 18.8% | 21.0% | 18.3% | 19.9% | 15.8% | |
| 4 | 21.8% | 21.8% | 20.3% | 23.1% | 23.7% | |
| 5 | 19.5% | 24.6% | 17.0% | 22.3% | 17.7% |
Statistics presented as means±SD or percentages unless otherwise indicated.
a
ANOVA P value.
b
Pearson chi-squared test P value.
c
Kruskal–Wallis test P value.